1/2:0.37、0.43、0.46 h;C0:4.72、8.7、15.5 mg/L;AUC0-t:1.57、2.84、6.21 mg·h/L。大鼠尾iv依托泊苷注射劑5 mg/L后的藥動(dòng)學(xué)參數(shù)分別為:t1/2為0.34 h,C0為7.53 mg/L,AUC0-t為2.63 mg·h/L。依托泊苷亞微乳給藥劑量在2.5~10 mg時(shí),t1/2無(wú)顯著差異,C0、AUC0-t呈劑量相關(guān)性,符合線性藥動(dòng)學(xué)特點(diǎn)。與注射劑比較,依托泊苷亞微乳的t1/2延長(zhǎng),AUC增大。結(jié)論 依托泊苷亞微乳的生物利用度有所提高,但半衰期仍然較短。;Objective To study the pharmacokinetic characteristics of Etoposide Submicron Emulsion in rats and compare with Etoposide Injection. Methods Rats were randomly divided into four groups, and each group had six rats. Etoposide Submicron Emulsion at doses of 2.5, 5, and 10 mg/kg and Etoposide Injection at dose of 5 mg/kg were iv administrated. Blood samples were collected at 0.033, 0.167, 0.333, 0.667, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, and 6 h. Etoposide in rat whole blood were determined by HPLC method. Results Pharmacokinetic parameters of Etoposide Submicron Emulsion were as follows: t1/2 0.37, 0.43, and 0.46 h, C0 4.72, 8.7, and 15.5 mg/L, AUC0-t 1.57, 2.84, and 6.21 mg·h/L, respectively. And pharmacokinetic parameters of Etoposide Injection were as follows: t1/2 0.34 h, C0 7.53 mg/L, and AUC0-t 2.63 mg·h/L. There was no significant difference of t1/2 for Etoposide Submicron Emulsion at dosage from 2.5 to 10 mg, while C0 and AUC0-t were both dose dependent. Etoposide Submicron Emulsion presented a linear pharmacokinetic behavior. Compared with Etoposide Injection, AUC and t1/2 of Etoposide Submicron Emulsion increased. Conclusion Bioavailability of Etoposide Submicron Emulsion is improved, but half-life is still relatively short."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁(yè) > 過(guò)刊瀏覽>2015年第30卷第8期 >2015,30(8):938-942. DOI:10.7501/j.issn.1674-5515.2015.08.007
上一篇 | 下一篇

依托泊苷亞微乳在大鼠體內(nèi)的藥動(dòng)學(xué)研究

Pharmacokinetic study of Etoposide Submicron Emulsion in rats

發(fā)布日期:2015-08-25